| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.02 |